Haidian district has gathered more than 30 core brain–computer interface (BCI)
companies, about 60% of China’s total, and has formed a full-chain innovation
ecosystem from basic research to clinical application, the Zhongguancun Science
City management committee said. During the 15th Five-Year Plan period Haidian
will promote a BCI clinical-translation industry innovation center, leverage a
global med‑health incubation platform and dedicated funds to accelerate R&D,
clinical validation and commercialization of invasive and semi‑invasive BCIs,
and push scale deployment and scenario expansion for non‑invasive BCIs to
establish a global industry benchmark.